Covered recipient · General Payments record
ANDREY TAKHTOVICH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$758.56
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $236.55 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $236.55 | 19 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Novo Nordisk Inc | $7.97 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096922926 | CMS |
| Novo Nordisk Inc | $5.67 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097219716 | CMS |
| Novo Nordisk Inc | $5.96 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096600067 | CMS |
| Novo Nordisk Inc | $6.69 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096831834 | CMS |
| Novo Nordisk Inc | $5.78 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097716409 | CMS |
| Novo Nordisk Inc | $6.30 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097342770 | CMS |
| Novo Nordisk Inc | $6.21 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096832214 | CMS |
| Novo Nordisk Inc | $8.53 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096649279 | CMS |
| Novo Nordisk Inc | $6.77 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097699021 | CMS |
| Novo Nordisk Inc | $10.69 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097349202 | CMS |
| Novo Nordisk Inc | $5.80 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097444228 | CMS |
| Novo Nordisk Inc | $8.55 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097549388 | CMS |
| Novo Nordisk Inc | $111.47 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096826730 | CMS |
| Novo Nordisk Inc | $5.97 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096722370 | CMS |
| Novo Nordisk Inc | $6.56 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097479318 | CMS |
| Novo Nordisk Inc | $7.33 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097598363 | CMS |
| Novo Nordisk Inc | $6.05 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097799885 | CMS |
| Novo Nordisk Inc | $6.55 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097327568 | CMS |
| Novo Nordisk Inc | $7.70 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096686464 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.